BRIEF-Shionogi Announces U.S. Availability Of Xocova® (Ensitrelvir), The First And Only Oral Option To Help Prevent Covid-19 Following Exposure*

July 28 (Reuters) – Shionogi & Co Ltd: * SHIONOGI ANNOUNCES U.S. AVAILABILITY OF XOCOVA® (ENSITRELVIR), THE FIRST AND ONLY ORAL OPTION TO HELP PREVENT COVID-19 FOLLOWING EXPOSURE* Source text: Further

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)